» Articles » PMID: 28483919

Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients

Abstract

Arterial stiffness and augmentation of aortic blood pressure (BP) measured in office are known cardiovascular risk factors in hemodialysis patients. This study examines the prognostic significance of ambulatory brachial BP, central BP, pulse wave velocity (PWV), and heart rate-adjusted augmentation index [AIx(75)] in this population. A total of 170 hemodialysis patients underwent 48-hour ambulatory monitoring with Mobil-O-Graph-NG during a standard interdialytic interval and followed-up for 28.1±11.2 months. The primary end point was a combination of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. Secondary end points included: (1) all-cause mortality; (2) cardiovascular mortality; and (3) a combination of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, coronary revascularization, or hospitalization for heart failure. During follow-up, 37(21.8%) patients died and 46(27.1%) had cardiovascular events. Cumulative freedom from primary end point was similar for quartiles of predialysis-systolic BP (SBP), 48-hour peripheral-SBP, and central-SBP, but was progressively longer for increasing quartiles for 48-hour peripheral-diastolic BP and central-diastolic BP and shorter for increasing quartiles of 48-hour central pulse pressure (83.7%, 71.4%, 69.0%, 62.8% [log-rank =0.024]), PWV (93.0%, 81.0%, 57.1%, 55.8% [log-rank <0.001]), and AIx(75) (88.4%, 66.7%, 69.0%, 62.8% [log-rank =0.014]). The hazard ratios for all-cause mortality, cardiovascular mortality, and the combined outcome were similar for quartiles of predialysis-SBP, 48-hour peripheral-SBP, and central-SBP, but were increasing with higher ambulatory PWV and AIx(75). In multivariate analysis, 48-hour PWV was the only vascular parameter independently associated with the primary end point (hazard ratios, 1.579; 95% confidence intervals, 1.187-2.102). Ambulatory PWV, AIx(75), and central pulse pressure are associated with increased risk of cardiovascular events and mortality, whereas office and ambulatory SBP are not. These findings further support that arterial stiffness is the prominent cardiovascular risk factor in hemodialysis.

Citing Articles

I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.

Rodrigues C, Ferreira-Filho S, Moura A, Poli-de-Figueiredo C, Silva D, Polacchini F J Bras Nefrol. 2025; 47(1):e20240033.

PMID: 40009791 PMC: 11864789. DOI: 10.1590/2175-8239-JBN-2024-0033en.


The Effect of Low Dialysate Sodium Concentration on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Patients With Intradialytic Hypertension: A Randomized Crossover Study.

Iatridi F, Theodorakopoulou M, Ekart R, Karagiannidis A, Malandris K, Xagas E Cureus. 2025; 17(1):e77079.

PMID: 39917119 PMC: 11801399. DOI: 10.7759/cureus.77079.


Osteoprotegerin and Vascular Dysfunction in Patients with Stage 3 Chronic Kidney Disease and Those without Renal Dysfunction: A Case-Control Study.

Matos T, Vitorino P, Orlow R, Melo A, Amorim D, Sousa G Arq Bras Cardiol. 2024; 121(11):e20240122.

PMID: 39607169 PMC: 11634311. DOI: 10.36660/abc.20240122.


Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients.

Pella E, Boutou A, Boulmpou A, Theodorakopoulou M, Karagiannidis A, Haddad N Int Urol Nephrol. 2024; 57(3):897-906.

PMID: 39467956 DOI: 10.1007/s11255-024-04260-w.


Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients.

Mayer C, Sarafidis P, Matschkal J, Theodorakopoulou M, Lorenz G, Karagiannidis A Clin Kidney J. 2024; 17(7):sfae172.

PMID: 39056069 PMC: 11270016. DOI: 10.1093/ckj/sfae172.